We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

BioLineRx’s BL-5010 Submitted for CE Mark Registration

News   Sep 11, 2015

 
BioLineRx’s BL-5010 Submitted for CE Mark Registration
 
 
Advertisement
 

RELATED ARTICLES

UK Researchers Set To Explore Human Challenge Studies for COVID-19 Vaccine Development

News

Researchers are set to explore a human challenge study with the virus that causes COVID-19, the first such study anywhere in the world.

READ MORE

Glutathione Precursor Improves Conditions Associated With Premature Aging in HIV Patients

News

An open-label clinical trial found that a glutathione precursor, GlyNAC, reverses premature aging in people with HIV.

READ MORE

NIH Study Designed To Identify Promising COVID-19 Treatments for Larger Clinical Trials

News

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today launched a study designed to determine whether certain approved therapeutics or investigational drugs in late clinical development show promise against COVID-19 and warrant advancement into larger clinical trials.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE